Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates

Go back to Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates

Accelerate Diagnostics (AXDX) Misses Q1 EPS by 1c

May 7, 2020 5:44 PM EDT

Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.39), $0.01 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $2.34 million versus the consensus estimate of $2.27 million.

"Our first quarter got off to a solid start, as sales, new contracts, and go-lives... More